Condition: Kidney Calculi; Ureteral Calculi · Sponsor: Avvio Medical
The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less or no discomfort. Eligible patients are male or females, age 21 or older, with a single urinary stone in the ureter. Participants will undergo the ELS procedure and then be evaluated 30 days later for the presence or absence of urinary stone fragments on a CT scan. Subjects who still have stone present at Day 30 will be evaluated again at Day 60. Other outcome measures will be changes in pain, quality of life, and return to normal daily activities/work.
This description comes directly from the study's public registry record.
Louis Marcoux · 415-887-2037 · louis.marcoux@avviomed.com
Always discuss trial participation with your own doctor first.
| Arizona State Urological Research Institute | Phoenix, Arizona, United States | Recruiting |
| Arkansas Urology Research Center | Little Rock, Arkansas, United States | Enrolling By Invitation |
| Michael G. Oefelein Clinical Trials | Bakersfield, California, United States | Active Not Recruiting |
| San Diego Clinical Trials | La Mesa, California, United States | Recruiting |
| Golden State Urology | Sacramento, California, United States | Recruiting |
| University of Miami Hospital | Miami, Florida, United States | Recruiting |
| Georgia Urology | Roswell, Georgia, United States | Recruiting |
| Comprehensive Urologic Care | Lake Barrington, Illinois, United States | Recruiting |
| Wichita Urology Group | Wichita, Kansas, United States | Recruiting |
| Minnesota Urology | Woodbury, Minnesota, United States | Recruiting |
| Nebraska Urology | Lincoln, Nebraska, United States | Enrolling By Invitation |
| Urology Nevada | Reno, Nevada, United States | Enrolling By Invitation |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06942949